The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Preclinical CRO Treatment-Global Market Insights and Sales Trends 2025
Synopsis
Preclinical contract research organizations (CROs) offer research and development services to pharmaceutical and biotechnology companies during the early stages of drug development, including preclinical studies and animal testing.
The global Preclinical CRO Treatment market size is expected to reach US$ 1612.8 million by 2029, growing at a CAGR of 12.2% from 2023 to 2029. The market is mainly driven by the significant applications of Preclinical CRO Treatment in various end use industries. The expanding demands from the Biopharmaceutical Companies, Government and Academic Institutes and Medical Device Companies,, are propelling Preclinical CRO Treatment market. Bioanalysis and DMPK Studies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Toxicology Testing segment is estimated at % CAGR for the next seven-year period.
The market for preclinical CRO services is driven by the demand for specialized expertise and resources in drug development and the need for efficient and cost-effective preclinical research. The market's growth is also influenced by the increasing outsourcing of preclinical studies by pharmaceutical and biotech companies.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Preclinical CRO Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Preclinical CRO Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Preclinical CRO Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Preclinical CRO Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Preclinical CRO Treatment covered in this report include Charles River Laboratories, Laboratory Corporation of America, Envigo, Eurofins Scientific, PRA Health Science, Wuxi Apptec Co.,Ltd., Medpace, Pharmaceutical Product Development and Paraxel, etc.
The global Preclinical CRO Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Charles River Laboratories
Laboratory Corporation of America
Envigo
Eurofins Scientific
PRA Health Science
Wuxi Apptec Co.,Ltd.
Medpace
Pharmaceutical Product Development
Paraxel
Pharmaron
Joinn Laboratories
Medicilon Inc.
Crown Bioscience
Yinuosi Bio-Technology
Global Preclinical CRO Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Preclinical CRO Treatment market, Segment by Type:
Bioanalysis and DMPK Studies
Toxicology Testing
Global Preclinical CRO Treatment market, by Application
Biopharmaceutical Companies
Government and Academic Institutes
Medical Device Companies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Preclinical CRO Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Preclinical contract research organizations (CROs) offer research and development services to pharmaceutical and biotechnology companies during the early stages of drug development, including preclinical studies and animal testing.
The global Preclinical CRO Treatment market size is expected to reach US$ 1612.8 million by 2029, growing at a CAGR of 12.2% from 2023 to 2029. The market is mainly driven by the significant applications of Preclinical CRO Treatment in various end use industries. The expanding demands from the Biopharmaceutical Companies, Government and Academic Institutes and Medical Device Companies,, are propelling Preclinical CRO Treatment market. Bioanalysis and DMPK Studies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Toxicology Testing segment is estimated at % CAGR for the next seven-year period.
The market for preclinical CRO services is driven by the demand for specialized expertise and resources in drug development and the need for efficient and cost-effective preclinical research. The market's growth is also influenced by the increasing outsourcing of preclinical studies by pharmaceutical and biotech companies.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Preclinical CRO Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Preclinical CRO Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Preclinical CRO Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Preclinical CRO Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Preclinical CRO Treatment covered in this report include Charles River Laboratories, Laboratory Corporation of America, Envigo, Eurofins Scientific, PRA Health Science, Wuxi Apptec Co.,Ltd., Medpace, Pharmaceutical Product Development and Paraxel, etc.
The global Preclinical CRO Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Charles River Laboratories
Laboratory Corporation of America
Envigo
Eurofins Scientific
PRA Health Science
Wuxi Apptec Co.,Ltd.
Medpace
Pharmaceutical Product Development
Paraxel
Pharmaron
Joinn Laboratories
Medicilon Inc.
Crown Bioscience
Yinuosi Bio-Technology
Global Preclinical CRO Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Preclinical CRO Treatment market, Segment by Type:
Bioanalysis and DMPK Studies
Toxicology Testing
Global Preclinical CRO Treatment market, by Application
Biopharmaceutical Companies
Government and Academic Institutes
Medical Device Companies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Preclinical CRO Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Preclinical CRO Treatment
1.1 Preclinical CRO Treatment Market Overview
1.1.1 Preclinical CRO Treatment Product Scope
1.1.2 Preclinical CRO Treatment Market Status and Outlook
1.2 Global Preclinical CRO Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Preclinical CRO Treatment Market Size by Region (2018-2029)
1.4 Global Preclinical CRO Treatment Historic Market Size by Region (2018-2023)
1.5 Global Preclinical CRO Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Preclinical CRO Treatment Market Size (2018-2029)
1.6.1 North America Preclinical CRO Treatment Market Size (2018-2029)
1.6.2 Europe Preclinical CRO Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Preclinical CRO Treatment Market Size (2018-2029)
1.6.4 Latin America Preclinical CRO Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Preclinical CRO Treatment Market Size (2018-2029)
2 Preclinical CRO Treatment Market by Type
2.1 Introduction
2.1.1 Bioanalysis and DMPK Studies
2.1.2 Toxicology Testing
2.2 Global Preclinical CRO Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Preclinical CRO Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Preclinical CRO Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Preclinical CRO Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Preclinical CRO Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Preclinical CRO Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Preclinical CRO Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Preclinical CRO Treatment Revenue Breakdown by Type (2018-2029)
3 Preclinical CRO Treatment Market Overview by Application
3.1 Introduction
3.1.1 Biopharmaceutical Companies
3.1.2 Government and Academic Institutes
3.1.3 Medical Device Companies
3.2 Global Preclinical CRO Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Preclinical CRO Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Preclinical CRO Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Preclinical CRO Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Preclinical CRO Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Preclinical CRO Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Preclinical CRO Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Preclinical CRO Treatment Revenue Breakdown by Application (2018-2029)
4 Preclinical CRO Treatment Competition Analysis by Players
4.1 Global Preclinical CRO Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Preclinical CRO Treatment as of 2022)
4.3 Date of Key Players Enter into Preclinical CRO Treatment Market
4.4 Global Top Players Preclinical CRO Treatment Headquarters and Area Served
4.5 Key Players Preclinical CRO Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Preclinical CRO Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Charles River Laboratories
5.1.1 Charles River Laboratories Profile
5.1.2 Charles River Laboratories Main Business
5.1.3 Charles River Laboratories Preclinical CRO Treatment Products, Services and Solutions
5.1.4 Charles River Laboratories Preclinical CRO Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Charles River Laboratories Recent Developments
5.2 Laboratory Corporation of America
5.2.1 Laboratory Corporation of America Profile
5.2.2 Laboratory Corporation of America Main Business
5.2.3 Laboratory Corporation of America Preclinical CRO Treatment Products, Services and Solutions
5.2.4 Laboratory Corporation of America Preclinical CRO Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Laboratory Corporation of America Recent Developments
5.3 Envigo
5.3.1 Envigo Profile
5.3.2 Envigo Main Business
5.3.3 Envigo Preclinical CRO Treatment Products, Services and Solutions
5.3.4 Envigo Preclinical CRO Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Eurofins Scientific Recent Developments
5.4 Eurofins Scientific
5.4.1 Eurofins Scientific Profile
5.4.2 Eurofins Scientific Main Business
5.4.3 Eurofins Scientific Preclinical CRO Treatment Products, Services and Solutions
5.4.4 Eurofins Scientific Preclinical CRO Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Eurofins Scientific Recent Developments
5.5 PRA Health Science
5.5.1 PRA Health Science Profile
5.5.2 PRA Health Science Main Business
5.5.3 PRA Health Science Preclinical CRO Treatment Products, Services and Solutions
5.5.4 PRA Health Science Preclinical CRO Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 PRA Health Science Recent Developments
5.6 Wuxi Apptec Co.,Ltd.
5.6.1 Wuxi Apptec Co.,Ltd. Profile
5.6.2 Wuxi Apptec Co.,Ltd. Main Business
5.6.3 Wuxi Apptec Co.,Ltd. Preclinical CRO Treatment Products, Services and Solutions
5.6.4 Wuxi Apptec Co.,Ltd. Preclinical CRO Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Wuxi Apptec Co.,Ltd. Recent Developments
5.7 Medpace
5.7.1 Medpace Profile
5.7.2 Medpace Main Business
5.7.3 Medpace Preclinical CRO Treatment Products, Services and Solutions
5.7.4 Medpace Preclinical CRO Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Medpace Recent Developments
5.8 Pharmaceutical Product Development
5.8.1 Pharmaceutical Product Development Profile
5.8.2 Pharmaceutical Product Development Main Business
5.8.3 Pharmaceutical Product Development Preclinical CRO Treatment Products, Services and Solutions
5.8.4 Pharmaceutical Product Development Preclinical CRO Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Pharmaceutical Product Development Recent Developments
5.9 Paraxel
5.9.1 Paraxel Profile
5.9.2 Paraxel Main Business
5.9.3 Paraxel Preclinical CRO Treatment Products, Services and Solutions
5.9.4 Paraxel Preclinical CRO Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Paraxel Recent Developments
5.10 Pharmaron
5.10.1 Pharmaron Profile
5.10.2 Pharmaron Main Business
5.10.3 Pharmaron Preclinical CRO Treatment Products, Services and Solutions
5.10.4 Pharmaron Preclinical CRO Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Pharmaron Recent Developments
5.11 Joinn Laboratories
5.11.1 Joinn Laboratories Profile
5.11.2 Joinn Laboratories Main Business
5.11.3 Joinn Laboratories Preclinical CRO Treatment Products, Services and Solutions
5.11.4 Joinn Laboratories Preclinical CRO Treatment Revenue (US$ Million) & (2018-2023)
5.11.5 Joinn Laboratories Recent Developments
5.12 Medicilon Inc.
5.12.1 Medicilon Inc. Profile
5.12.2 Medicilon Inc. Main Business
5.12.3 Medicilon Inc. Preclinical CRO Treatment Products, Services and Solutions
5.12.4 Medicilon Inc. Preclinical CRO Treatment Revenue (US$ Million) & (2018-2023)
5.12.5 Medicilon Inc. Recent Developments
5.13 Crown Bioscience
5.13.1 Crown Bioscience Profile
5.13.2 Crown Bioscience Main Business
5.13.3 Crown Bioscience Preclinical CRO Treatment Products, Services and Solutions
5.13.4 Crown Bioscience Preclinical CRO Treatment Revenue (US$ Million) & (2018-2023)
5.13.5 Crown Bioscience Recent Developments
5.14 Yinuosi Bio-Technology
5.14.1 Yinuosi Bio-Technology Profile
5.14.2 Yinuosi Bio-Technology Main Business
5.14.3 Yinuosi Bio-Technology Preclinical CRO Treatment Products, Services and Solutions
5.14.4 Yinuosi Bio-Technology Preclinical CRO Treatment Revenue (US$ Million) & (2018-2023)
5.14.5 Yinuosi Bio-Technology Recent Developments
6 North America
6.1 North America Preclinical CRO Treatment Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Preclinical CRO Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Preclinical CRO Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Preclinical CRO Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Preclinical CRO Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Preclinical CRO Treatment Market Dynamics
11.1 Preclinical CRO Treatment Industry Trends
11.2 Preclinical CRO Treatment Market Drivers
11.3 Preclinical CRO Treatment Market Challenges
11.4 Preclinical CRO Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
